IBS
The company announced a deal with Indegene to launch Regulora, its recently FDA-approved prescription digital therapeutic for treating abdominal pain associated with IBS.
Berlin startup targets irritable bowel syndrome and other gastrointestinal problems with a digital therapy program.
Regulora delivers behavioral therapy based on gut-directed hypnotherapy through a smartphone app.
The London-based company is backing a 300-person UPenn study comparing its digital therapeutic to the consumer wellness app.
Mahana Therapeutics' Parallel is a three-month digital treatment that logs patients' symptoms to deliver relevant guidance and teach them condition-management skills.
Roundup: NHS Tayside launches app to help IBS sufferers, Thirona launches COVID-19 detection softwa…
Also, Livi and North Tyneside CCG partnership gives 220,000 people free access to digital consultations.
The company is also sponsoring a free video consultation for the first 400 people accessing the service.
Zemedy is an app targeted at treating irritable bowel syndrome symptoms through a combination of CBT, hypnotherapy exercises and stress management techniques.
The startup said that the seed funding will support continued development of Regulora, its behavioral intervention delivered through a mobile platform.
The IB-Stim device adheres behind the patient's ear for up to five days, and may assist with pain reduction for up to three consecutive weeks.